Ozempic has quickly become a cornerstone in healthcare, addressing two critical challenges: type 2 diabetes and obesity. As a GLP-1 receptor agonist, its promise of glycemic control and significant weight loss has captured the attention…
By 2040, the number of new cancer cases per year is projected to rise to 29.5 million, with cancer-related deaths expected to reach 16.4 million globally. These staggering statistics underscore the need for effective treatments,…
In 2024, the Mpox virus outbreak—formerly monkeypox—continues to demand the attention of Doctors around the globe. Earlier this year, Africa’s top public health body announced the virus to be spreading quickly, with more than 17,000…
59% of patients associate a physician’s bedside manner to the quality of care received from a health care facility, according to a physician survey. These patients also revealed the importance of compassion, comfort, and patience in their interactions with…
Importance of studying tumors and clinical trial designs Cancer remains one of the leading causes of death globally. In the past couple of decades cancer research has received a lot of attention. Researchers have dedicated…
Innovative technology solutions such as CRISPR and artificial intelligence (AI) are changing the approach to cancer diagnosis and treatment. Pharmaceutical and medical device companies that produce new oncology drugs and medical products benefit from physician…
Cancer clinical trials are indispensable for improving and expanding the arsenal of treatments available in oncology. Not only that, but clinical trials are invaluable to clinicians as we read about them in peer-reviewed journals, often…
Advances in cancer treatments have increased the number of cancers treated using immunotherapy. The percentage of patients selected for immune checkpoint inhibitor drugs – a subtype of immunotherapy – has increased from 1.54% in 2011 to 43.63% in…
A tumor board, also referred to as a cancer treatment board, is a vital treatment planning process where a multidisciplinary team of cancer doctors and healthcare specialists come together regularly to evaluate and discuss complex…
In recent years, real-world data (RWD) and real-world evidence (RWE) are experiencing a renaissance in cancer treatment. However, real-world evidence comes with its own pros and cons, raising important questions. Why is RWE becoming more…